RESOLVE THERAPEUTICS
Resolve Therapeutics is a private biotechnology company that is dedicated to the goal of improving the lives of patients suffering from lupus. They are focused on the advancement their exciting, novel biologic compound, RSLV-125 from preclinical research through a phase IIa clinical trial. The company is based on the pioneering discoveries made by Dr. Keith Elkon and Dr. Jeff Ledbetter in their laboratories at the University of Washington School of Medicine.
RESOLVE THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
Kirkland, Washington, United States
Country:
United States
Website Url:
http://www.resolvebio.com
Total Employee:
1+
Status:
Active
Contact:
425-576-4100
Total Funding:
8.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Google Google Cloud
Current Advisors List
Current Employees Featured
Founder
Investors List
New Science Ventures
New Science Ventures investment in Series B - Resolve Therapeutics
Washington Research Foundation
Washington Research Foundation investment in Series B - Resolve Therapeutics
Easton Capital
Easton Capital investment in Series B - Resolve Therapeutics
New Science Ventures
New Science Ventures investment in Series A - Resolve Therapeutics
Easton Capital
Easton Capital investment in Series A - Resolve Therapeutics
Official Site Inspections
http://www.resolvebio.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
